Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Role of Mitochondria in the Development of HIV Atrophy
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Listed as NCT00119405, this observational or N/A phase trial focuses on HIV Infections and Lipodystrophy and remains completed. Sponsored by National Institute of Allergy and Infectious Diseases (NIAID), it has been updated 11 times since 2005, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 6 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
May 2017 — Aug 2017 [monthly]
Completed NA
Status: Unknown Status → Completed · Phase: PHASE2 → NA
-
Jan 2017 — May 2017 [monthly]
Unknown Status PHASE2
First recorded
Apr 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Allergy and Infectious Diseases (NIAID)
For direct contact, visit the study record on ClinicalTrials.gov .